Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease – Novartis

BrainCo has filed confidentially for a Hong Kong initial public offering, according to people familiar with the matter, putting it…

Heineken’s CEO told CNBC that AI will play an “important part of ongoing productivity savings” after the brewer said it…